PURIXAN
These highlights do not include all the information needed to use PURIXAN safely and effectively. See full prescribing information for PURIXAN. PURIXAN (mercaptopurine) oral suspension Initial U.S. Approval: 1953
Approved
Approval ID
9fd27952-7787-47d9-b6cf-7af2dc38217b
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Oct 10, 2022
Manufacturers
FDA
Nova Laboratories, Ltd
DUNS: 230804692
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Purixan
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code62484-0020
Application NumberNDA205919
Product Classification
M
Marketing Category
C73594
G
Generic Name
Purixan
Product Specifications
Route of AdministrationORAL
Effective DateFebruary 28, 2018
FDA Product Classification
INGREDIENTS (1)
MercaptopurineActive
Quantity: 20 mg in 1 mL
Code: E7WED276I5
Classification: ACTIB